BeOne Medicines Ltd. Ratios

Ratios Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 97.91%85.52%77.12%85.98%79.77%84.55%84.41%
EBT Margin -142.28%-647.71%-11,136.73%-38.20%-348.01%-523.90%-123.93%-138.50%-33.59%-13.99%
EBIT Margin -120.88%-643.66%-10,940.19%-41.30%-356.05%-536.69%-57.51%-126.40%-49.12%-14.91%
EBITDA Margin -120.88%-643.66%-10,940.19%-41.30%-356.05%-536.69%-57.51%-126.40%-49.12%-14.91%
Operating Margin -120.88%-643.66%-10,940.19%-41.30%-356.05%-536.69%-57.51%-126.40%-49.12%-14.91%
Net Margin -140.22%-647.71%-11,141.78%-39.06%-347.33%-527.27%-123.93%-141.52%-35.86%-16.92%
FCF Margin -71.71%-512.22%-10,562.15%-14.10%-311.77%-453.57%-78.78%-128.68%-69.93%-16.62%
Efficiency
Inventory Average 0.01B0.02B0.06B0.17B0.26B0.35B0.46B
Assets Average 0.26B0.73B1.65B1.93B3.61B7.07B7.01B5.64B5.86B
Equity Average -0.08B0.13B0.52B1.22B1.37B2.42B5.00B5.26B3.96B3.43B
Invested Capital -0.05B-0.09B0.35B0.69B1.79B0.98B4.20B6.56B4.68B4.23B3.50B
Asset Utilization Ratio 0.000.330.120.090.170.200.440.65
Leverage & Solvency
Debt to Equity -0.200.050.230.090.160.130.100.120.250.31
Debt Ratio 0.180.040.150.070.100.090.070.090.150.17
Equity Ratio -0.870.870.650.780.610.690.720.800.610.56
Valuation
Enterprise Value -0.01B0.84B0.63B6.86B6.41B9.08B18.85B18.79B18.29B15.68B17.06B
Market Capitalization 0.94B1.00B7.68B8.18B10.05B23.50B25.41B22.83B18.86B19.69B
Return Ratios
Return on Sales -1.42%-6.48%-111.42%-0.39%-3.40%-5.27%-1.24%-1.42%-0.36%-0.17%
Return on Capital Employed -0.52%-0.17%-0.50%-0.59%-0.65%-0.12%-0.29%-0.32%-0.16%
Return on Invested Capital -0.55%
Return on Assets -0.46%-0.13%-0.41%-0.49%-0.45%-0.21%-0.29%-0.16%-0.11%
Return on Equity 0.74%-0.95%-0.18%-0.55%-0.70%-0.67%-0.29%-0.38%-0.22%-0.19%